Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Anthony P. Morreale, PharmD, BCPS, MBA

Articles by Anthony P. Morreale, PharmD, BCPS, MBA

Assessment of Patient Satisfaction with a Formulary Switch from Omeprazole to Lansoprazole in Gastroesophageal Reflux Disease Maintenance Therapy

ByLaura J. Condra, PharmD,Anthony P. Morreale, PharmD, BCPS, MBA,Stephen N. Stolley, PharmD, BCPS,David Marcus, RPh

May 1st 1999

Latest Updated Articles

Assessment of Patient Satisfaction with a Formulary Switch from Omeprazole to Lansoprazole in Gastroesophageal Reflux Disease Maintenance Therapy
Published: May 1st 1999 | Updated:

Trending on AJMC

FDA Approves Use of Subcutaneous Pembrolizumab for NSCLC

Iron Dysregulation Linked to MS Progression, Review Finds

FDA Approves Ruxolitinib Cream for Patients as Young as 2 Years With Atopic Dermatitis

Early Linvoseltamab Use Prevents Myeloma Progression: Paula Rodríguez-Otero, MD, PhD

Efficacy of Ruxolitinib Cream in Nonsegmental Vitiligo Confirmed in Real-World Study

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

© 2025 MJH Life Sciences^®

All rights reserved.